Kantify at Knowledge for Growth 2026

On 3–4 June, Kantify will participate in Knowledge for Growth in Antwerp — now in its 22nd year, and Europe's largest regional health innovation conference.

Our CEO Ségolène Martin will speak in the session Tech for One Health: AI & computational drug discovery, alongside Christophe Deben (Sightera Biosciences), Wouter Van Putte (PUXANO), and Liesbeth Minnoye (VIB-UGent).

The session examines how computational methods are being applied to therapeutic problems — not as a replacement for experiment, but as a way to reduce the number of failed iterations between hypothesis and validation.

For Kantify, that means discussing how we use Sapian, our AI platform for drug discovery, to explore untapped chemical space, even in the toughest cases, i.e. the undruggable.

Why K4G matters

Knowledge for Growth convenes more than 1,200 delegates from across health and biotech: academic labs, biotech founders, pharma business development teams, medtech companies, agtech innovators, and the investors who back them. L

The format is built around intersections — between medical and industrial biotech, between digital health and drug discovery, between early academic work and late-stage commercial programmes. It is one of the few European conferences where scientific depth and deal-making coexist without one diminishing the other.

Belgium, and Flanders in particular, has constructed a biotech infrastructure that exceeds what its size would suggest: productive academic institutes (VIB, UGent, KU Leuven), regulatory proximity to the EMA, a network of CDMOs and service providers, and a policy environment that supports early-stage risk capital. K4G sits at the centre of that ecosystem — and reflects its ambition to remain competitive as computational methods reshape how drugs are discovered.

For Kantify, participating means staying connected to the labs where new therapeutic hypotheses originate, and to the partners who can help translate those hypotheses into clinical candidates.

What we'll discuss

The Tech for One Health session focuses on how AI and computational methods are being deployed — and where they still fall short. Our contribution will centre on four areas where Sapian has changed how we work:

• Hit discovery for intractable targets: generating chemical matter for proteins that lack known small molecule binders — targets where traditional screening has failed or where structural information is limited.

• Target selection: identifying which proteins are druggable, and which modalities are most likely to succeed against them.

• ADMET prediction: estimating pharmacokinetic and toxicity liabilities before synthesis, to avoid costly late-stage failures.

• Scaffold optimisation: navigating chemical space more efficiently by learning from both successful and failed molecules.

If you're attending

Knowledge for Growth runs 3–4 June 2026 at Flanders Meeting & Convention Center Antwerp. Full programme and registration details are available at knowledgeforgrowth.be.

If you want to discuss how Sapian approaches target validation, molecule design, or how we work with academic labs and biotech companies, reach out via hello@kantify.com.

Knowledge for Growth is organised by Flanders Investment & Trade and supported by the Government of Flanders.